© 1993 Oxford University Press
research-article |
Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair
Laboratory of Molecular Pharmacology, Division of Cancer Treatment Bldg 37, Room 5C-25, National Cancer Institute NIH, Bethesda, MD 20892, USA
1To whom correspondence should be addressed at Laboratory of Molecular Genetics, National Institute on Aging, NIH, 4940 Eastern Ave, Baltimore, MD 21224, USA
Using specific inhibitors we have assessed the role of topoisomerases I and II in DNA repair of the overall genome and in both strands of an essential gene, the dihydrofolate reductase (DHFR) gene in chinese hamster ovary (CHO) cells. In these studies we have: (1) used inhibitors of topoisomerases during the repair incubation and (2) studied the DNA repair in cells with altered levels of topoisomerase activity. When cells were allowed to repair after UV irradiation, the gene-specific DNA repair was not affected by either topoisomerase I or topoisomerase II inhibitors alone. However, when topoisomerase I and topoisomerase II inhibitors were added simultaneously the gene- and strand-specific DNA repair were markedly inhibited. In contrast, the overall genome DNA repair was only marginally affected. This suggests that topoisomerases are involved in gene-specific DNA repair and that one type may substitute for the other in the repair process. That concept is further supported by our findings using a mutant cell line with a decreased level of topoisomerase I: gene-specific DNA repair can be inhibited by a topoisomerase II inhibitor alone. By analyzing the steady-state expression of the DHFR gene we find that inhibition of repair in the DHFR gene is not ascribed to an obvious change in the messenger level. Furthermore, using agents other than UV, we observe that the inhibitors have no effect on gene-specific repair of DNA damage introduced by the chemotherapeutic agents cisplatin and nitrogen mustard.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Yu, E. Khan, M. A. Khaleque, J. Lee, G. Laco, G. Kohlhagen, S. Kharbanda, Y.-C. Cheng, Y. Pommier, and A. Bharti Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity J. Biol. Chem., December 10, 2004; 279(50): 51851 - 51861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Christensen, R. M. Krokowski, H. U. Barthelmes, R. Hock, F. Boege, and C. Mielke Distinct Effects of Topoisomerase I and RNA Polymerase I Inhibitors Suggest a Dual Mechanism of Nucleolar/Nucleoplasmic Partitioning of Topoisomerase I J. Biol. Chem., May 21, 2004; 279(21): 21873 - 21882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mielke, M. O. Christensen, H. U. Barthelmes, and F. Boege Enhanced Processing of UVA-irradiated DNA by Human Topoisomerase II in Living Cells J. Biol. Chem., May 14, 2004; 279(20): 20559 - 20562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Christensen, H. U. Barthelmes, F. Boege, and C. Mielke Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro Nucleic Acids Res., December 15, 2003; 31(24): 7255 - 7263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Therrien, R. Drouin, C. Baril, and E. A. Drobetsky Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair PNAS, December 21, 1999; 96(26): 15038 - 15043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Hengstler, J. Lange, A. Kett, N. Dornhofer, R. Meinert, M. Arand, P. G. Knapstein, R. Becker, F. Oesch, and B. Tanner Contribution of c-erbB-2 and Topoisomerase II{{alpha}} to Chemoresistance in Ovarian Cancer Cancer Res., July 1, 1999; 59(13): 3206 - 3214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Straub, P. Grue, A. Uhse, M. Lisby, B. R. Knudsen, T. O. Tange, O. Westergaard, and F. Boege The RNA-splicing Factor PSF/p54 Controls DNA-Topoisomerase I Activity by a Direct Interaction J. Biol. Chem., October 9, 1998; 273(41): 26261 - 26264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Tanswell, O. Staub, R. Iles, R. Belcastro, J. Cabacungan, L. Sedlackova, B. Steer, Y. Wen, J. Hu, and H. O'Brodovich Liposome-mediated transfection of fetal lung epithelial cells: DNA degradation and enhanced superoxide toxicity Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L452 - L460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fritz, S. H. Elsea, P. I. Patel, and M. S. Meyn Overexpression of a truncated human topoisomerase III partially corrects multiple aspects of the ataxia-telangiectasia phenotype PNAS, April 29, 1997; 94(9): 4538 - 4542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Meyer, E. Kjeldsen, T. Straub, B. R. Knudsen, I. D. Hickson, A. Kikuchi, H. Kreipe, and F. Boege Cell Cycle-coupled Relocation of Types I and II Topoisomerases and Modulation of Catalytic Enzyme Activities J. Cell Biol., February 24, 1997; 136(4): 775 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lanza, S. Tornaletti, C. Rodolfo, M. C. Scanavini, and A. M. Pedrini Human DNA Topoisomerase I-mediated Cleavages Stimulated by Ultraviolet Light-induced DNA Damage J. Biol. Chem., March 22, 1996; 271(12): 6978 - 6986. [Abstract] [Full Text] [PDF]
|
|